A Trial-Based Cost-Effectiveness Analysis of Erlotinib Alone versus Platinum-Based Doublet Chemotherapy as First-Line Therapy for Eastern Asian Nonsquamous Non–Small-Cell Lung Canc...

by Wang, Siying, Peng, Liubao, Li, Jianhe, Zeng, Xiaohui, Ouyang, Lihui, Tan, Chongqing, Lu, Qiong
Published 2013

Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis

by Zeng, Xiaohui, Li, Jianhe, Peng, Liubao, Wang, Yunhua, Tan, Chongqing, Chen, Gannong, Wan, Xiaomin, Lu, Qiong, Yi, Lidan
Published 2014

Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China

by Tan, Chongqing, Peng, Liubao, Zeng, Xiaohui, Li, Jianhe, Wan, Xiaomin, Chen, Gannong, Yi, Lidan, Luo, Xia, Zhao, Ziying
Published 2013